ConductScience.org, home

Paper7008932

Laboratory and clinical research in breast cancer--a personal adventure: the David A. Karnofsky memorial lecture.

Fisher B. Cancer Res, 1980. Cited by 339 papers, by iCite.

Cite this record

ConductScience Library. Laboratory and clinical research in breast cancer--a personal adventure: the David A. Karnofsky memorial lecture. Papers, record 7008932. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7008932

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Laboratory and clinical research in breast cancer--a personal adventure: the David A. Karnofsky memorial lecture.
PubMed
Journal
Cancer Res
PubMed
Year
1980
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
339
iCite
Relative citation ratio, by iCite
7.94
iCite
Revised in PubMed
2004-11-17
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fisher BB

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Age Factors
Female
Humans
Lymph Node Excision
Lymph Nodes
Lymphatic Metastasis
Mastectomy
Research Design

Source PubMed

Download CSV of topics

Cited by108

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 339 citations.

PMIDTitleJournalYearIn PapersSource
42488634Survival outcomes of axillary de-escalation following neoadjuvant chemo-immunotherapy in clinically node-positive triple-negative breast cancer: a national cancer database study.Front Immunol2026https://conductscience.org/library/papers/42488634PubMed
42213262The Past, Present, and Future of Sentinel Lymph Node Biopsy in Breast Cancer.Ann Surg Oncol2026https://conductscience.org/library/papers/42213262PubMed
41815550De-escalating breast and axillary surgery in breast cancer: evidence, controversies, and future directions.Front Oncol2026https://conductscience.org/library/papers/41815550PubMed
41580815Healing dynamics and surgery in breast cancer: rethinking a timeless challenge in light of advancing therapies and technologies.J Transl Med2026https://conductscience.org/library/papers/41580815PubMed
40772038Complementary detection strategies for circulating tumor cells in breast cancer: clinical implications of combining immunofluorescence and cytopathological staining.Front Oncol2025https://conductscience.org/library/papers/40772038PubMed
40263543Evolutionary paths towards metastasis.Nat Rev Cancer2025https://conductscience.org/library/papers/40263543PubMed
39953281Lymph node yield as a surrogate marker for tumour biology and prognosis in colon cancer.Br J Cancer2025https://conductscience.org/library/papers/39953281PubMed
39717616The History of Breast Cancer Early Detection: 1865 - 2020.Breast Cancer (Dove Med Press)2024https://conductscience.org/library/papers/39717616PubMed
39570418[Detection of circulating tumor cells in women with early breast cancer].Rev Med Inst Mex Seguro Soc2024https://conductscience.org/library/papers/39570418PubMed
39037646Clinical Tumor Dormancy.Methods Mol Biol2024https://conductscience.org/library/papers/39037646PubMed
38940900Cancer metastasis through the lymphatic versus blood vessels.Clin Exp Metastasis2024https://conductscience.org/library/papers/38940900PubMed
38730576Axillary Surgery for Breast Cancer in 2024.Cancers (Basel)2024https://conductscience.org/library/papers/38730576PubMed
38248105Review on Lymph Node Metastases, Sentinel Lymph Node Biopsy, and Lymphadenectomy in Sarcoma.Curr Oncol2024https://conductscience.org/library/papers/38248105PubMed
37415650Treatment Changes in Breast Cancer Management and De-Escalation of Breast Surgery.Eur J Breast Health2023https://conductscience.org/library/papers/37415650PubMed
37149414Lymph nodes: at the intersection of cancer treatment and progression.Trends Cell Biol2023https://conductscience.org/library/papers/37149414PubMed
37106239Local treatment in oligometastasis from breast cancer: an overview.Clin Transl Oncol2023https://conductscience.org/library/papers/37106239PubMed
36826153Stereotactic Radiation for Oligometastatic and Oligoprogressive Stage IV Breast Cancer: A Case-Based Review.Curr Oncol2023https://conductscience.org/library/papers/36826153PubMed
36826069Management of Oligometastatic Breast Cancer: An Expert Committee's Opinion.Curr Oncol2023https://conductscience.org/library/papers/36826069PubMed
36087082Five decades of progress in surgical oncology: Breast.J Surg Oncol2022https://conductscience.org/library/papers/36087082PubMed
35756663Radiotherapy in Oligometastatic, Oligorecurrent and Oligoprogressive Prostate Cancer: A Mini-Review.Front Oncol2022https://conductscience.org/library/papers/35756663PubMed

See all 108 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7008932

GET https://conductscience.org/api/papers/v1/7008932/cited_by?page=2